Tobam Danaher Corp Transaction History

Tobam

$638 Million
Q2 2024

A detailed history of Tobam transactions in Danaher Corp stock. As of the latest transaction made, Tobam holds 1,240 shares of DHR stock, worth $341,545. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,240

Previous 1,240 -0.0%

Holding current value

$341,545

Previous $310,000 -0.0%

% of portfolio

0.05%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$235.51 - $267.98 $413,791 - $470,840	-1,757 Reduced 58.63%	1,240 $310,000
Q4 2023 Jan 26, 2024	SELL	$185.1 - $233.13 $57,566 - $72,503	-311 Reduced 9.4%	2,997 $693,000
Q3 2023 Oct 31, 2023	SELL	$233.08 - $265.59 $31,232 - $35,589	-134 Reduced 3.89%	3,308 $821,000
Q1 2023 May 03, 2023	BUY	$239.75 - $277.0 $189,402 - $218,830	790 Added 29.79%	3,442 $868,000
Q4 2022 Feb 02, 2023	SELL	$241.42 - $282.29 $189,756 - $221,879	-786 Reduced 22.86%	2,652 $704,000
Q3 2022 Nov 02, 2022	BUY	$247.06 - $1507.4 $28,411 - $173,351	115 Added 3.46%	3,438 $888,000
Q2 2022 Aug 02, 2022	BUY	$237.11 - $299.66 $52,164 - $65,925	220 Added 7.09%	3,323 $842,000
Q1 2022 Apr 25, 2022	BUY	$257.27 - $315.76 $287,113 - $352,388	1,116 Added 56.17%	3,103 $910,000
Q4 2021 Feb 15, 2022	SELL	$292.08 - $329.01 $39,430 - $44,416	-135 Reduced 6.36%	1,987 $654,000
Q2 2021 Aug 11, 2021	BUY	$225.08 - $271.69 $159,131 - $192,084	707 Added 49.96%	2,122 $569,000
Q1 2021 May 11, 2021	BUY	$212.38 - $245.9 $99,818 - $115,573	470 Added 49.74%	1,415 $318,000
Q4 2020 Feb 03, 2021	BUY	$212.5 - $245.46 $55,037 - $63,574	259 Added 37.76%	945 $210,000
Q3 2020 Nov 12, 2020	BUY	$177.16 - $215.33 $121,531 - $147,716	686 New	686 $148,000

Others Institutions Holding DHR

# of Institutions

2,389

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $201B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account